Results 91 to 100 of about 2,440,020 (219)

Establishment of age-related AMH screening cutoffs in Chinese women with PCOS: a retrospective study using propensity score matching analysis

BMC Endocrine Disorders
Background Polycystic ovary syndrome (PCOS) is a common endocrine disorder that affects 5–18% of women worldwide. This disorder is characterized by two core pathological features: ovulatory dysfunction and hyperandrogenism.
Zhen Wang, Xiaojing Teng, Yanfei Liu, Yonghai Shen, Lin Ma, Yu Chen   +5 more
doaj   +1 more source

Anti-Mullarian Hormone As A Diagnostic Marker of Polycystic Ovary Syndrome

Pakistan Armed Forces Medical Journal
Objective: To determine the utility of Anti-mullerian hormone (AMH) as a diagnostic marker of Polycystic ovarian syndrome (PCOS). Study Design: Comparative cross-sectional study Place and Duration of the Study: Department of Chemical Pathology and ...
Shabana Abbas, Asma Hayat, Rabiya Shabir, Muhammad Mujahid Sharif, Asma Iqbal, Rehana Abbas   +5 more
doaj   +1 more source

Autosomal Recessive Segregation of a Truncating Mutation of Anti-Müllerian Type II Receptor in a Family Affected by the Persistent Müllerian Duct Syndrome Contrasts with Its Dominant Negative Activity in Vitro.

, 2001
International audienceAnti-Müllerian hormone belongs to the TGFbeta family whose members exert their effects by signaling through two related serine/threonine kinase receptors.
Dutertre, Martin, Imbeaud, Sandrine, Lins, Laurence, Josso, Nathalie, Belville, Corinne, Picard, Jean-Yves, Hughes, Ieuan, Gouédard, Lucile, Di Clemente, Nathalie, Messika-Zeitoun, Liza   +9 more
core   +1 more source

Incretin‐Based Medications in Women and Reproduction: A Systematic Scoping Review and Consensus Guidelines for Clinical Practice

Obesity Reviews, EarlyView.
ABSTRACT Introduction Pregnancy concurrent with incretin‐based medications is contraindicated due to unknown risk of teratogenicity, as is breastfeeding. The aim of this systematic scoping review was to investigate potential risks and benefits of incretin‐based medications in relation to preconception, pregnancy, and postnatal health, and to propose ...
Kate Maslin, Jill Shawe, Sinead Blowers, Michael Ceulemans, Kathryn Hart, Sam Schoenmakers, Amihai Rottenstreich, Heather Hopper, Mojca Jensterle, Angela C. Flynn, Sarah Siegelaar, Annick Bogaerts, Isy Douek, Nicola Heslehurst, Dries Ceulemans, Tricia Tan, Johnathan Pinkney, Martin Whyte, Shahrad Taheri, Roland Devlieger   +19 more
wiley   +1 more source

Delayed menopausal transition in polycystic ovary syndrome: A call for research on age‐dependent phenotypes and different ethnic populations

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
Johanna Lavi, Maarit Niinimäki, Terhi Piltonen   +2 more
wiley   +1 more source

Exploring lifestyle management in polycystic ovary syndrome through implementation frameworks

Experimental Physiology, EarlyView.
Abstract Polyendocrine metabolic ovarian syndrome [PMOS; previously known as polycystic ovary syndrome (PCOS)] is an endocrine condition affecting 10%–13% of women of reproductive age, with cardiometabolic, reproductive and psychological features. The PMOS guidelines have established recommendations for its management, which can include pharmacological,
Margaret McGowan, Stephanie Cowan, Chau Thien Tay, Lisa J. Moran, Ashley H. Ng   +4 more
wiley   +1 more source

Anti-Müllerian hormone receptor defect

, 2006
International audienceAnti-Müllerian hormone (AMH), produced by gonadal somatic cells, is mainly responsible for the regression of Müllerian ducts--the anlagen of uterus and Fallopian tubes--during male sex differentiation.
Belville, Corinne, Di Clemente, Nathalie
core   +1 more source

AMH measurement is being overused—Are you guilty?

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
Antti Perheentupa
wiley   +1 more source

Expanded Phenotype Associated With an Intronic PPP1R12A Variant: A Case Report and Literature Review

American Journal of Medical Genetics Part A, Volume 200, Issue 11, Page 2519-2524, November 2026.
ABSTRACT Autosomal dominant PPP1R12A‐related genitourinary and/or brain malformation syndrome is a recently described multisystem disorder caused by loss‐of‐function variants in the protein phosphatase 1 regulatory subunit 12a (PPP1R12A) gene. To date, 22 affected individuals have been reported with variable brain malformations and genitourinary ...
Emily M. Bland, Amber Nakar Weinstein, Eric C. Kao, Xiaonan Zhao, Monika Weisz‐Hubshman   +4 more
wiley   +1 more source

A novel mutation in the anti-müllerian hormone gene as cause of persistent müllerian duct syndrome.

, 2001
International audiencePersistent müllerian duct syndrome is a relatively rare inherited defect of sexual differentiation characterised by failure of regression of the müllerian ducts in males. In affected individuals, uterus and tubes are present because
Belville, C., Picard, Jy., Lang-Muritano, M, Biason-Lauber, A, Gitzelmann, C, Schoenle, E   +5 more
core   +1 more source